Skip to main content

Table 1 Enrolled and non-enrolled potentially eligible patients

From: A prospective study investigating gross motor function of children with cerebral palsy and GMFCS level II after long-term Botulinum toxin type A use

Group NCP Type
N (%)
Last GMFCS
N (%)
Comorbidity = Yes
N (%)
Total number lower limb BoNTA received by an individual
Median (IQR)
Indicationa
N
Age (yrs) first BoNTA
Median (IQR)
Age (yrs) last BoNTA
Median (IQR)
N (%) children undergoing surgery
N by indication
Age (yrs) first surgery
Median (IQR)
Non-enrolled 27Hemiplegia 9 (34)Stable 17 (63)12 (44.4)7 (5.5, 14.5)Improve function 154 (2, 6)10 (8, 11)8 (30) Total
5 Gait only
1 Hips only
2 Hip and Gait
7.5 (4, 11)
Diplegia 16 (59)Improved 7 (26)Manage symptoms 3
Quadriplegia 2 (7)Deteriorated 3 (11)Care and comfort 2
Enrolled 28Hemiplegia 13 (46)Stable 22 (78)15 (54)11 (6.71, 5.5)Improve function 233.5 (2, 6)10 (8.5, 11)4 (14) Gait only 9 (7, 11)
Diplegia 15 (54)Improved 6 (22)Manage symptoms 1
Deteriorated 0 (0)
  1. aThe data fields concerning these indications for use were introduced into the database only in 2013 so data for this field is incomplete